Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Trends & Forecasts

Business & Regulation Trends & Forecasts

Medicine Making in Europe

| Stephanie Sutton

EFPIA figures give a snapshot of drug development and innovation in Europe. Check out our infographic for some of the key stats.

Business & Regulation Business Practice

Facing the Brexit Trial

| James Strachan

No-deal Brexit poses unique challenges for the development and advanced therapy sectors, not least tight timelines and a limited ability to stockpile.

Business & Regulation Trends & Forecasts

Business-in-Brief

| Stephanie Sutton

Gene therapy deals, clinical trials transparency and sartan medicine reviews… what’s new for pharma in business?

Business & Regulation Trends & Forecasts

The Pharma Playground

| Stephanie Sutton

As ever, our industry will have to deal with its fair share of sociopolitical “fun” in 2019. But what can we do?

Business & Regulation Trends & Forecasts

Pharma in the Firing Line

| George Chressanthis, Charlie Thompson

With the US back to divided government, the US pharma industry could be the number one target for politicians.

Business & Regulation Drug Discovery

Here's to New Beginnings

| Stephanie Sutton

Conversations around drug pricing look set to continue for years, but the industry is also experiencing fantastic breakthroughs in science.

Business & Regulation Profession

Power to You!

| James Strachan

2019 Power List nominations close in just one month. Who’s in the running? Well, that’s up to you…

Business & Regulation Advanced Medicine

What it Takes to Bloom

| James Strachan

Cell and gene therapies can live up to their potential – the field just needs to transform medicine as we know it.

Business & Regulation Trends & Forecasts

Always the Bridesmaid...

| Gavin Yamey

The pharma industry understands the importance of neglected diseases, but the field is still not receiving the attention it deserves.

Business & Regulation Trends & Forecasts

Withdrawal Symptoms

| James Strachan

Brexit: As UK politicians debate the merits of the Prime Minister’s Withdrawal Agreement, we debate its potential impact for pharma...

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register